Download presentation
Presentation is loading. Please wait.
Published byDarrell Scot Gaines Modified over 6 years ago
1
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek, Anetta Undas, Jonathan H. Foley, Michael E. Nesheim, Konrad Jabłonski, Tomasz Mach Journal of Crohn's and Colitis Volume 6, Issue 1, Pages (February 2012) DOI: /j.crohns Copyright © 2011 European Crohn's and Colitis Organisation Terms and Conditions
2
Figure 1 Correlations between TAFIa and a) white blood cells, b) CRP, c) fibrinogen, d) albumin, and e) activity in patients with ulcerative colitis. Journal of Crohn's and Colitis 2012 6, 13-20DOI: ( /j.crohns ) Copyright © 2011 European Crohn's and Colitis Organisation Terms and Conditions
3
Figure 2 Correlations between TAFIa and a) platelets, b) CRP, c) fibrinogen, and d) albumin in patients with Crohn's disease. Journal of Crohn's and Colitis 2012 6, 13-20DOI: ( /j.crohns ) Copyright © 2011 European Crohn's and Colitis Organisation Terms and Conditions
4
Figure 3 Dispersion graphs of the TAFIa for: active Crohn's disesase (CDactive), nonactive Crohn's disease (CDnactiv), active ulcerative colitis (UCactiv) and nonactive ulcerative colitis (UCnactiv). Journal of Crohn's and Colitis 2012 6, 13-20DOI: ( /j.crohns ) Copyright © 2011 European Crohn's and Colitis Organisation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.